15%
YR1 Revenue Increase
Designing a New Operating Model for MedTech R&D
idfmarketing2021-09-03T10:47:46+00:0035%
Reduction in program delivery times
Leveraging In-House Expertise to Develop New Services
idfmarketing2021-09-03T10:49:04+00:0012%
Growth in ancillary revenue